Cefepime

This classification denotes a cephalosporin antibiotic with the molecular formula C19H24N6O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 807PW4VQE3, chemically known as 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(z)-(o-methyloxime) but generally known as cefepime, which bears US NIH Compound Identifier 5479537. European Medicines Agency schedules Cefepime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07390MIG. The term CEFEPIME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules cefepime in its Anatomical Therapeutic Chemical (ATC) Classification. CEFEPIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefepime under HS 29419000 and SITC 54139. As of Q4 2014, CEFEPIME remains the US FDA Preferred Term for this commodity. Cefepime bears US NLM identifiers UMLS ID C0055003 and NCI Concept Code C65294. SMILES: S1C2N(C(=C(C[N]3(CCCC3)C)C1)C(=O)O)C(=O)C2NC(=O)/C(=N\OC)C1NC(SC1)N.